Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

Darden's Portfolio Strength: Are All Segments Finally Firing Together?
Darden's Portfolio Strength: Are All Segments Finally Firing Together?

Darden Restaurants DRI is increasingly demonstrating that its multi-brand portfolio is operating in sync, a notable shift from the uneven performance seen in prior periods. In the third quarter of

Pre-markets Lower on Concerns About Iran
Pre-markets Lower on Concerns About Iran

Thursday, April 2nd, 2026Pre-market futures are off early morning lows, but still fairly deep in the red at this hour. Following a prime-time speech from President Trump yesterday, where investors

Recurring Subscription Revenues & Buyouts Aid Verisk Amid High Debt
Recurring Subscription Revenues & Buyouts Aid Verisk Amid High Debt

Verisk VRSK is benefiting from its recurring subscription-based revenue model. Rising direct premium growth and a robust liquidity position are driving VRSK’s sustainable growth. Recent acquisitions

Can Group Ordering and Catering Support Sales Recovery for Chipotle?
Can Group Ordering and Catering Support Sales Recovery for Chipotle?

Chipotle Mexican Grill, Inc. CMG is focusing on new demand channels to revive sales momentum. Group ordering and catering are emerging as key opportunities as the company looks to drive higher

NIKE's Gross Margin Drag & Tariff Costs Loom: Can It Protect Profits?
NIKE's Gross Margin Drag & Tariff Costs Loom: Can It Protect Profits?

Gross margin pressure remains a central concern for NIKE, Inc. NKE as tariff-related costs and ongoing marketplace clean-up efforts weigh on near-term profitability. The company continues to

3 Growth Stocks From the P&C Insurance Space to Enhance Your PortfolioPhoto, wide shot, wide-angle lens, soft focus,  Risk management company, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-vkrXsXVXnZepYEkiT4BvjtCA.png?st=2023-05-14T13%3A27%3A43Z&se=2023-05-14T15%3A27%3A43Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-14T00%3A09%3A01Z&ske=2023-05-15T00%3A09%3A01Z&sks=b&skv=2021-08-06&sig=y1VhH4rrtYGKSVOHO3rBwhpmvE42GCwp7%2BKdLaLI7kA%3D
3 Growth Stocks From the P&C Insurance Space to Enhance Your Portfolio

The Zacks Property and Casualty Insurance industry is placed within the top 16% of the 243 Zacks industries. It currently carries Zack Industry Rank #38. The insurers remain well-poised for growth

OCGN Completes Early Enrollment in Pivotal Stargardt Disease Study
OCGN Completes Early Enrollment in Pivotal Stargardt Disease Study

Ocugen OCGN announced that enrollment and dosing have been completed in the phase II/III GARDian3 pivotal confirmatory study evaluating its pipeline candidate, OCU410ST, for the treatment of

SpaceX IPO Set to Be a Catalyst for 2026 IPO Boom: ETFs to Gain
SpaceX IPO Set to Be a Catalyst for 2026 IPO Boom: ETFs to Gain

Elon Musk’s SpaceX has taken the next step toward a landmark IPO by confidentially filing with the SEC, setting the stage for a potentially record-setting public offering, as reported by Bloomberg

Shell Reportedly Targets New Venezuelan Gas Areas to Boost LNG SupplyPhoto, wide shot, wide-angle lens,  Coal company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.midjourneyapi.xyz/temp/2a011bdc-adca-4de9-8457-d868b31178cf.png
Shell Reportedly Targets New Venezuelan Gas Areas to Boost LNG Supply

Shell plc SHEL is reportedly advancing negotiations with Venezuela’s government to expand its presence in the country’s most promising offshore natural gas fields. The London-based integrated oil

Is Procter & Gamble's Supply Chain 3.0 a Catalyst for Margin Growth?
Is Procter & Gamble's Supply Chain 3.0 a Catalyst for Margin Growth?

The Procter & Gamble Company’s PG next-generation Supply Chain 3.0 initiative is emerging as a critical pillar in the company’s long-term productivity and margin expansion strategy. As consumer

Waste Services Expertise Aids WM Amid High Debt & Low Liquidity
Waste Services Expertise Aids WM Amid High Debt & Low Liquidity

WM WM is benefiting from its robust infrastructure and extensive asset network in the waste removal services industry. A stable industry that provides essential services is driving WM’s sustainable

JNJ Q1 MedTech Preview: Key Drivers and China Headwinds to Watch
JNJ Q1 MedTech Preview: Key Drivers and China Headwinds to Watch

Johnson & Johnson's JNJ MedTech division, which spans orthopedics, surgery, cardiovascular and vision care, contributes roughly 36% to the company’s total revenues.

J&J is repositioning its MedTech

3 Reasons to Hold Microsoft Stock Despite 28.6% Drop in 6 MonthsPhoto, wide shot, wide-angle lens,  Telecom equipment supplier, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/ad10ed87-71d0-4096-a50b-ba9470f8264b.png
3 Reasons to Hold Microsoft Stock Despite 28.6% Drop in 6 Months

Microsoft MSFT has had a rough run in recent months, with its stock shedding 28.6% in the past six-month period, underperforming the Zacks Computer and Technology sector's decline of 7.9% as the

Earnings Preview: Neogen (NEOG) Q3 Earnings Expected to Decline
Earnings Preview: Neogen (NEOG) Q3 Earnings Expected to Decline

The market expects Neogen (NEOG) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended February 2026. This widely-known consensus outlook is

Earnings Preview: Simply Good Foods (SMPL) Q2 Earnings Expected to Decline
Earnings Preview: Simply Good Foods (SMPL) Q2 Earnings Expected to Decline

Simply Good Foods (SMPL) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended February 2026. This widely-known consensus

Analysts Estimate Byrna Technologies Inc. (BYRN) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate Byrna Technologies Inc. (BYRN) to Report a Decline in Earnings: What to Look Out for

Wall Street expects a year-over-year decline in earnings on higher revenues when Byrna Technologies Inc. (BYRN) reports results for the quarter ended February 2026. While this widely-known

5 Small Drug Stocks to Buy as Sector Recovery Gains StrengthPhoto, wide shot, wide-angle lens,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png
5 Small Drug Stocks to Buy as Sector Recovery Gains Strength
The drug and biotech sector has been in a recovery mode since mid-2025, after going through a difficult period between 2021 and 2023 backed by strong quarterly results, surging mergers and
ROKU Slumps 12% YTD: Here's Why It Is Time to Buy the Stock
ROKU Slumps 12% YTD: Here's Why It Is Time to Buy the Stock

Roku Inc. ROKU shares have experienced significant volatility and a notable 12% year-to-date (YTD) decline, underperforming the broader Zacks Consumer Discretionary sector and the Zacks Broadcast

Best Momentum Stocks to Buy for April 2nd
Best Momentum Stocks to Buy for April 2nd

Here is a stock with buy rank and strong momentum characteristics for investors to consider today, April 2:

Flowco Holdings Inc. FLOC: This provider of production optimization, artificial lift and

Wall Street Analysts See a 41.29% Upside in NeuroPace (NPCE): Can the Stock Really Move This High?
Wall Street Analysts See a 41.29% Upside in NeuroPace (NPCE): Can the Stock Really Move This High?

Shares of NeuroPace, Inc. (NPCE) have gained 0.9% over the past four weeks to close the last trading session at $14.07, but there could still be a solid upside left in the stock if short-term price

Wall Street Analysts Predict a 201.49% Upside in Aura Biosciences (AURA): Here's  What You Should Know
Wall Street Analysts Predict a 201.49% Upside in Aura Biosciences (AURA): Here's What You Should Know

Aura Biosciences, Inc. (AURA) closed the last trading session at $6.7, gaining 8.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Wall Street Analysts Predict a 25.11% Upside in Marex Group PLC (MRX): Here's  What You Should Know
Wall Street Analysts Predict a 25.11% Upside in Marex Group PLC (MRX): Here's What You Should Know

Marex Group PLC (MRX) closed the last trading session at $43.05, gaining 7.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Wall Street Analysts Predict a 75.44% Upside in nCino (NCNO): Here's  What You Should Know
Wall Street Analysts Predict a 75.44% Upside in nCino (NCNO): Here's What You Should Know

nCino (NCNO) closed the last trading session at $16.57, gaining 1.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

Wall Street Analysts Think vTv Therapeutics (VTVT) Could Surge 31.58%: Read This Before Placing a Bet
Wall Street Analysts Think vTv Therapeutics (VTVT) Could Surge 31.58%: Read This Before Placing a Bet

vTv Therapeutics (VTVT) closed the last trading session at $40.53, gaining 12.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Wall Street Analysts Predict a 107.82% Upside in Vor Biopharma (VOR): Here's  What You Should Know
Wall Street Analysts Predict a 107.82% Upside in Vor Biopharma (VOR): Here's What You Should Know

Shares of Vor Biopharma Inc. (VOR) have gained 15.6% over the past four weeks to close the last trading session at $17.39, but there could still be a solid upside left in the stock if short-term